| SpectraBase Spectrum ID |
JH918OPS3Jg |
| Name |
Ethyltryptamine PFO |
| Classification |
Tryptamine designer drug derivative |
| Copyright |
Copyright © 2024-2025 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
584.094485555 u |
| Formula |
C20H15F15N2O |
| InChI |
InChI=1S/C20H15F15N2O/c1-2-10(7-9-8-36-12-6-4-3-5-11(9)12)37-13(38)14(21,22)15(23,24)16(25,26)17(27,28)18(29,30)19(31,32)20(33,34)35/h3-6,8,10,36H,2,7H2,1H3,(H,37,38) |
| InChIKey |
ZVHQSDVWMZYNCK-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
584.329 g/mol |
| Nominal Mass |
584 u |
| Quality |
962 |
| Retention Index |
4284 |
| SMILES |
C(C(C(C(C(NC(CC=1C=2C(NC1)=CC=CC2)CC)=O)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F |
| SPLASH |
splash10-001i-1900000000-b3a4c5512d5190943e9c |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Etryptamine PFO
2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluoro-N-(1-(1H-indol-3-yl)butan-2-yl)octanamide |
| Technique |
GC/MS |
| Wiley ID |
DD2024_001377 |
